In a study conducted by Foj et al. (2017), it was demonstrated that both miR-375 and miR-21 are significantly upregulated in intermediate and high risk PCa patients as copare to low risk and healthy population and could discriminate between PCa and non-PCa participants that had shown high PSA levels. The gene discussed is PLAG1; the disease is posterior cortical atrophy.